Lawmakers are poking holes in pharma’s favorite new way to market medicines

A new way of sell­ing med­ica­tions has land­ed phar­ma­ceu­ti­cal com­pa­nies in law­mak­ers’ crosshairs.

Ear­li­er this year, Eli Lil­ly un­veiled a ser­vice called Lil­ly­Di­rect to con­nect …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.